Agree that existing shareholders should have been given top up opportunity.
Looking at last 4C cash received from sales this quarter was up around 10% from last quarter which is better than flat. Given lag from when sales are booked for P&L and when they are paid you'd expect further growth in next quarter.
Not sure TUTA does blood bags anymore as this area highly commoditised. Their focus is more plastic lines, burettes etc. But I'm with you I'd like to know churn rates on contracts.
Hopefully we'll get more clarity with earnings announcement and AGM.
MLA Price at posting:
23.0¢ Sentiment: Buy Disclosure: Held
